Saturday 21 October
1130 - 1600 Multiple Sclerosis Group Editorial Board (restricted)
Sunday 22 October
0800 - 1800 Cochrane Collaboration Steering Group (restricted)
0900 - 1700 GRADE Working Party (restricted)
1100 - 1700 Consumer Satellite Event Session 1 (restricted)
1200 - 1700 Editorial Management Advisory Group (restricted)
1730 - 2000 Information Management System Support Team (restricted)
1800 - 1900 Consumer Satellite Event Session 2 (restricted)
1800 - 2100 Handbook Advisory Group (restricted)
Monday 23 October
0900 - 1130 Applicability and Recommendations Method Group
0900 - 1330 Consumer Satellite Event Session 3 (restricted)
0900 - 1530 Centre Directors (restricted)
0900 - 1700 Co-ordinating Editors (restricted)
0900 - 1500 Review Group Co-ordinators (restricted)
0900 - 1500 Trials Search Co-ordinators (restricted)
1000 - 1100 Consumer Network - CAM Working Group
1100 - 1230 All Fields (restricted)
1100 - 1230 Reporting Bias Methods Group
1330 - 1430 IPD MA Methods Group (restricted)
1330 - 1500 Diagnostic Test Reviews Initiative (restricted)
1330 - 1500 Thomas Chalmers Award Committee 1st Meeting (restricted)
1330 - 1530 Primary Health Care Field
1330 - 1530 Systematic Reviews and Electronic Decision Support
1400 - 1500 Health Care of Older People Field
1600 - 1800
Cochrane training in Ireland
Tuesday 24 October
0700 - 0900 Developing Country Network Co-ordinating Group (restricted)
0700 - 0900 Monitoring and Registration Group (restricted)
0700 - 0900 EPOC open Meeting
0745 - 0845 Back Group
0745 - 0900 Quality Advisory Group (restricted)
0800 - 0900 Consumer Network Ethics Working Group (restricted)
0800 - 0900 Methods Group Co-convenors Meeting - Closed
0800 - 0900 Musculoskeletal
0800 - 0900 Neonatal Group
1130 - 1230 New Interface Working Party (restricted)
1230 - 1315 Colloquium Manager (restricted)
1230 - 1315 Consumers and Communication Review Group
1230 - 1315 Lunch Meeting for new TSCs of Cochrane Review Groups, Fields and Centres (restricted)
1230 - 1315 Breast Cancer Group
1230 - 1330 Pain, Palliative and Supportive Care Group Editors
1530 - 1700 Acute Respiratory Infections Group
1530 - 1700 Cochrane French-speaking Network: how, why, for whom?
1530 - 1700 Qualitative Research Methods Group
1530 - 1700 Complementary Medicines Field
1530 - 1700 Consumer Network Special Management (restricted)
1530 - 1700 Evidence Aid (restricted)
1530 - 1700 Funding Working Party (restricted)
1530 - 1700 Haematological Malignancies Group
1530 - 1700 Joint Meeting of RGCs/TSCs/Co-eds (restricted)
1530 - 1700 Menstrual Disorders and Subfertility Group
1530 - 1700 National Digital Libraries of Health
1530 - 1700 Open Developing Countries Network
1530 - 1700 Statistical Methods Group
1530 - 1700 Surrogate Therapeutics incl work done with statisticians
| This meeting will now take place on either the 13 or 14
November at the National Cancer Institute in Washington DC. If you are
interested in attending please contact either Kent Johnson (kent.johnson doesnotexist@cochrane.org newcastle.edu.au) or Marissa Lasser (marissa.lassere doesnotexist@cochrane.org sesiahs.health.nsw.gov.au) for further details. |
1530 - 1700 US Contributors
1530 - 1700 Web Content Advisory Group (restricted)
1700 - 1830 BMJ Reception (restricted)
1715 - 1815 Anaesthesia Group
1715 - 1815 Bone, Joint and Muscle Trauma Editorial Group (restricted)
1715 - 1800 HIV/AIDS Group and STD Group Joint Meeting
1715 - 1815 Oral Health Group
1715 - 1815 Peripheral Vascular Diseases Group Editorial Team
1800 - 1930 HIV/AIDS Group and STD Group Joint Editorial Team (restricted)
1930 - 2200 Skin Group
Wednesday 25 October
0700 - 0900 Non-Randomised Studies Methods Group
0730 - 0830 Methodology Review Group Editorial Board (restricted)
0745 - 0900 Pregnancy and Childbirth Group Contributors
0800 - 0900 Canadian Contributors
0800 - 0900 Consumer Network AGM
0800 - 0900 Economics Methods Group Annual Business Meeting
0800 - 0900 Infectious Diseases Group
0830 - 0900 Possible Genomics Field
1230 - 1315 Child Heath Field
1230 - 1315 Cochrane News and CCInfo Advisory Committee (restricted)
1230 - 1315 Colloquium Abstracts Website
1230 - 1315 Continental European Entities RGCs
1230 - 1315 Information Retrieval Methods Group
1230 - 1315 Italian Reviewers
1500 - 1730 Consumers and Communication Review Group Editorial Board (restricted)
1530 - 1630 Gynaecological Cancer
1530 - 1700 Centre Staff (restricted)
1530 - 1700 Ear, Nose and Throat Disorders Group
1530 - 1700 Depression, Anxiety and Neurosis Group Editorial (restricted)
1530 - 1700 Health Promotion and Public Health Field
1530 - 1700 Injuries Group
1530 - 1700 Neurological Network
1530 - 1700 Pain, Palliative and Supportive Care Group
1530 - 1700 Perinatal work-in (restricted)
1530 - 1700 Proposed Adverse Effects Methods Group Exploratory Meeting
1530 - 1700 Screening and Diagnostic Tests Methods Group
1530 - 1700 Systematic reviews of studies or prognosis - towards a Prognosis Methods Group
1530 - 1730 Heart Group
1600 - 1700 Metabolic and Endocrine Disorders Contributors
1630 - 1830 Systematic reviews on prevention of cervical cancer
1700 - 1830 Iberoamerican Contributors
1715 - 1815 Cochrane participation in EU programmes
Thursday 26 October
0700 - 0900 Umbrella Reviews Working Group
0730 - 0900 Colloquium Policy Advisory Group (restricted)
0730 - 0900 Co-ordinating Editors of Department of Health funded Cochrane Review Groups (restricted)
0800 - 0900 Health Promotion & Public Health Field (HPPH) & Health Equity Field Joint Meeting (restricted)
0800 - 0830 Primary Health Care Field (restricted)
1230 - 1530 Cochrane Collaboration Steering Group - Closed
1230 - 1330 Cochrane Library Users Group
1230 - 1330 Neuromuscular Disease Group
1230 - 1330 Thomas Chalmers Award Committee 2nd Meeting (restricted)
Friday 27 October
0900 - 1200 Renal Group Editors (restricted)
0900 - 1230 Information Management System Team (restricted)
0900 - 1700 MANGA Study Group (restricted)
0930 - 1330 Colloquium Policy Advisory Group (restricted)
1000 - 1130 Discussion on the creation of a cervical cancer prevention group (restricted)
1100 - 1530 Ottawa Group dialogue on principles of registration of trial results - open (TBC)